CStone Pharmaceuticals (HKG:2616)
Hong Kong
· Delayed Price · Currency is HKD 9.49
+0.07 (0.74%)
Apr 29, 2026, 4:08 PM HKT
CStone Pharmaceuticals Employees
CStone Pharmaceuticals had 136 employees as of December 31, 2025. The number of employees increased by 1 or 0.74% compared to the previous year.
Employees
136
Change (1Y)
1
Growth (1Y)
0.74%
Revenue / Employee
2.21M HKD
Profits / Employee
-3.58M HKD
Market Cap
15.15B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Ascentage Pharma Group International | 767 |
| CARsgen Therapeutics Holdings | 355 |
| Everest Medicines | 812 |
| Zai Lab | 1,784 |
| Ascletis Pharma | 208 |
| HBM Holdings | 272 |
| Alphamab Oncology | 498 |
| Keymed Biosciences | 1,625 |
CStone Pharmaceuticals News
- 9 days ago - CStone Presented Preclinical Data for Three Novel or Differentiated ADCs at AACR 2026, Including CS5007 (EGFR/HER3) - PRNewsWire
- 4 weeks ago - CStone Announces 2025 Annual Results: Accelerated Expansion of Global Commercial Footprint and Efficient Advancement of Innovation Pipeline 2.0 - PRNewsWire
- 4 weeks ago - CStone Updated Clinical Progress and Key Phase I/II Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody) - PRNewsWire
- 2 months ago - CStone Announces MHRA Approval in UK for Sugemalimab in Stage III NSCLC - PRNewsWire
- 2 years ago - CStone Pharmaceuticals Earnings Call Transcript: H1 2023 - Transcripts